最新ニュース SPDR Gold MiniShares Trust (ARCA:GLDM)

The Shares are designed for investors who want a cost-effective and convenient way to invest in gold. Advantages of investing in the Shares include ease and flexibility of investment and expenses.

SPDR Gold MiniShares Trust

Throughout the last three months, 4 analysts have evaluated BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $3.88, a high estimate of $6.00, and a low estimate of $2.50. A negative shift in sentiment is evident as analysts have decreased the average price target by 24.22%. 
<img src="https://www.benzinga.com/files/images/story/2025/1741201255_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive BRC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$3.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>George Kelly</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.50</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$4.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to BRC. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of BRC compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of BRC's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of BRC's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BRCC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on BRC analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind BRC</h2>
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. it is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
<h3>Key Indicators: BRC's Financial Health</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, BRC faced challenges, resulting in a decline of approximately -11.51% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: BRC's net margin excels beyond industry benchmarks, reaching -2.34%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): BRC's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -17.92%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -1.08%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 7.34, BRC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

BRCC

What Analysts Are Saying About BRC Stock

Oceaneering International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $26.25, along with a high estimate of $30.00 and a low estimate of $22.00. Witnessing a positive shift, the current average has risen by 6.4% from the previous average price target of $24.67.
<img src="https://www.benzinga.com/files/images/story/2025/1741201247_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Oceaneering International's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$30.00</td>
<td>-</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$27.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Oceaneering International. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Oceaneering International compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Oceaneering International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Oceaneering International's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/OII/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Oceaneering International analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Oceaneering International's Background</h2>
Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.
<h3>Oceaneering International's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Oceaneering International showcased positive performance, achieving a revenue growth rate of 8.99% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Oceaneering International's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.86% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.94%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Oceaneering International's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.39% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Oceaneering International's debt-to-equity ratio is below the industry average. With a ratio of 1.19, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Oceaneering International: What You Need To Know

4 analysts have shared their evaluations of NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.0, a high estimate of $20.00, and a low estimate of $14.00. This current average reflects an increase of 24.36% from the previous average price target of $13.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1741201236_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of NeuroPace among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ross Osborn</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Larry Biegelsen</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Priya Sachdeva</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$17.00</td>
<td>-</td>
</tr>
<tr>
<td>Robbie Marcus</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to NeuroPace. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of NeuroPace compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of NeuroPace's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into NeuroPace's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NPCE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on NeuroPace analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About NeuroPace</h2>
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
<h3>Unraveling the Financial Story of NeuroPace</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: NeuroPace displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 28.2%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: NeuroPace's net margin excels beyond industry benchmarks, reaching -25.89%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -55.33%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): NeuroPace's ROA stands out, surpassing industry averages. With an impressive ROA of -5.72%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 7.48, NeuroPace faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NPCE

What 4 Analyst Ratings Have To Say About NeuroPace

4 analysts have expressed a variety of opinions on Chimerix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRX#NASDAQ">CMRX</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $10.39, a high estimate of $11.00, and a low estimate of $8.55. A decline of 5.55% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1741201225_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Chimerix among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Edward White</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.55</td>
<td>$11.00</td>
</tr>
<tr>
<td>Edward White</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Edward White</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Edward White</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Chimerix. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Chimerix compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Chimerix's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Chimerix's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CMRX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Chimerix analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Chimerix's Background</h2>
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
<h3>Financial Insights: Chimerix</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Chimerix showcased positive performance, achieving a revenue growth rate of 136.36% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Chimerix's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -87996.15%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Chimerix's ROE excels beyond industry benchmarks, reaching -15.7%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Chimerix's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -13.57%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Chimerix's debt-to-equity ratio is below the industry average at 0.0, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CMRX

Demystifying Chimerix: Insights From 4 Analyst Reviews

8 analysts have expressed a variety of opinions on Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.88, a high estimate of $66.00, and a low estimate of $54.00. Observing a 3.79% increase, the current average has risen from the previous average price target of $59.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1741201217_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Global E Online is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Kunal Madhukar</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$64.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Mark Zgutowicz</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$64.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Justin Patterson</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$63.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$66.00</td>
<td>$63.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Global E Online. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Global E Online compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Global E Online's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Global E Online's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GLBE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Global E Online analyst ratings.</a>
<h2>Unveiling the Story Behind Global E Online</h2>
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate global, direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce.
<h3>Global E Online: A Financial Overview</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Global E Online's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 49.41%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Global E Online's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.57%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Global E Online's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.17%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Global E Online's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.12%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLBE

What Analysts Are Saying About Global E Online Stock

Biotech

News

Events

General

HOTH

Hoth Therapeutics Announces Results For HT-001

WIIM

GIFT

Giftify shares are trading higher after the company launched sports ticket, merchandise savings platform.

The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) is reportedly implementing a new wave of job cuts, eliminating around 200 positions within its ABC News Group and Disney Entertainment <a target="_blank" href="https://www.benzinga.com/quote/DIS" rel="noreferrer noopener">Networks divisions.</a>
These reductions account for almost 6% of the total staff across both units, reported the<a target="_blank" href="https://www.wsj.com/business/media/disney-to-cut-nearly-6-staff-across-abc-news-disney-entertainment-networks-8af04b40" rel="noreferrer noopener"> Wall Street Journal</a>.
ABC programs, such as popular titles like &#8220;20/20&#8221; and &#8220;Nightline,&#8221; are being combined into one unit, per the report.
Also, significant adjustment is reportedly being made to Good Morning America show. The report indicates that all three hours of the program will now be managed by a single leader, replacing the current setup with separate teams for each hour.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/03/44143576/apples-latest-macbook-air-with-m4-chip-is-twice-as-fast-as-its-predecessor-with-lower-price" rel="noreferrer noopener">Apple&#8217;s Latest MacBook Air With M4 Chip Is Twice As Fast As Its Predecessor With Lower Price</a>
Additionally, the data-driven news platform 538 will be shut down as part of the cost-cutting measures, the report highlighted.
Since the beginning of 2023, the company has already reduced its workforce by more than 8,000 jobs, according to a report from <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-03-05/disney-cuts-6-of-abc-network-and-entertainment-tv-workforce?sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a>.
The report noted Disney has experienced a drop in both revenue and profit from its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43489835/the-walt-disney-company-reports-first-quarter-earnings-for-fiscal-2025" rel="noreferrer noopener">broadcast and cable TV sectors.</a>
In its latest quarter, Content Sales/Licensing and Other operating income increased $536 million to $312 million, driven by Moana 2&#8217;s performance.
The company has also trimmed its content budget to $23 billion, down from its <a target="_blank" href="https://www.benzinga.com/general/entertainment/25/02/43520895/disney-cuts-content-budget-by-1-billion-as-it-pushes-for-efficiency-house-of-mouse-says-too-early-to-revise-guidance-despite-earnings-beat" rel="noreferrer noopener">previous $24 billion allocation.</a>
Disney reported fiscal first-quarter 2025 revenue growth of 5% to $24.70 billion, beating the analyst estimate of $24.62 billion. Adjusted EPS of $1.76 beat the consensus <a href="https://www.benzinga.com/general/entertainment/25/02/43520895/disney-cuts-content-budget-by-1-billion-as-it-pushes-for-efficiency-house-of-mouse-says-too-early-to-revise-guidance-despite-earnings-beat">estimate of $1.45.</a>
Disney ended the quarter with 178 million Disney+ Core and Hulu subscriptions and 125 million Disney+ Core paid subscribers.
Price Action: DIS shares are trading higher by 0.05% at $109.06 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44140237/coreweave-acquires-weights-biases-to-enhance-ai-development" target="_blank" rel="noreferrer noopener">Nvidia Backed CoreWeave Acquires AI Developer Platform Weights &amp; Biases</a></li>
</ul>
Image via Shutterstock.

Entertainment

Equities

Media

Disney Cuts 200 Jobs Across ABC News And Disney Entertainment Networks: Report

Unum Group shares are trading higher after Raymond James upgraded the stock from Market Perform to Strong Buy and announced a price target of $108.

Macro Economic Events

Politics

Economics

National Security Adviser Waltz Has Been Talking To His Ukrainian Counterparts; Reconsidering Funding For Ukraine; Talks On Mineral Deal Are Happening; Trump Committed To Peace Deal

TKO Group shares are trading higher after Seaport Global upgraded the stock from Neutral to Buy and announced a price target of $164.

President Trump Is Open To Hearing About Additional Tariff Exemptions

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares are trading higher on Wednesday. Investors may be assessing trade policy along with President Donald Trump&#8217;s plans to make interest payments on automobile loans tax deductible for <a href="https://www.benzinga.com//node/44135215">U.S.-made vehicles.</a>
The Details: According to Reuters, the Trump administration is contemplating suspending the 25% tariff on imports from Canada and Mexico for certain products that comply with the USMCA trade agreement, which primarily affects the automotive industry.
Specifically, automakers could be granted a 30-day exemption from the tariffs. However, for the exemption to become permanent, the companies would need to demonstrate plans to invest more in U.S. automobile production.
On Tuesday, Trump met with the CEOs of Ford, General Motors, and Stellantis to discuss the potential 30-day exception. Vehicle manufacturers are open to increasing their investments in the U.S. auto sector, but they are seeking clarity on tariff policies and environmental regulations
Continued tariffs on Canadian and Mexican imports would significantly increase costs for automakers like Ford. Investors may be reacting positively to the possibility of a tariff exemption.
During his congressional address earlier this week, Trump mentioned plans to make interest payments on automobile loans tax deductible for U.S.-made vehicles, per <a href="https://www.usatoday.com/story/money/2025/03/05/trump-tax-break-car-loan-interest/81490546007/">USA Today</a>. This could incentivize consumers to purchase U.S.-made cars, potentially boosting profits for automobile makers. Investors may also be reacting positively to this potential boost.
See Also: <a href="https://www.benzinga.com/25/03/44146820/this-krystal-biotech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday">This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday</a>
F Price Action: At the time of writing, Ford stock is moving 4.51% higher at $9.53, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

What's Going On With Ford Stock Wednesday?

XPO shares are trading lower after B of A Securities cut its price target on the stock from $170 to $150.

Two experienced <a href="https://www.benzinga.com/general/social-media/24/03/37879478/humble-beginnings-like-nvidia-reddit-was-founded-inside-a-restaurant">social media entrepreneurs</a> are uniting in an effort to bring back Digg, the former "homepage of the internet."
What Happened: Digg founder Kevin Rose and Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) co-founder Alexis Ohanian have teamed up to acquire and reboot Digg, a move that comes while Ohanian is also part of a<a href="https://www.benzinga.com/general/social-media/25/03/44100560/reddit-co-founder-alexis-ohanian-joins-frank-mccourts-tiktok-bid-amid-competition-from-mrbeast-jesse-tinsley-and-reid-rasner"> group bidding to acquire</a> social media platform TikTok.
"Two OG internet founders &amp; former rivals team up with goal of using AI to bring humanity back to social media," a press release announcing the reboot of Digg <a href="https://www.prnewswire.com/news-releases/alexis-ohanian--kevin-rose-buy-back-social-platform-digg-302392419.html">reads</a>.
The duo have a plan to restore the old spirt of discovery and community of Digg and Reddit along with new growth plans to bring the platform into the new era, according to the release. 
Digg will use AI and other tools to fight off misinformation, spam and hostile interactions, all items that keep users off of social media.
"Digg plans to become an online destination with humanity and connection at its core."
Users can sign up for early access for when invites go public. A <a href="https://reboot.digg.com/">counter</a> shows 189,000 signups as of Wednesday afternoon.
"The front page of the internet, now with superpowers," the website reads.
"At various times over the years I had been approached to repurchase Digg; it never felt right. The technologies to solve our biggest pain points didn't exist," Rose said.
Rose will serve as Digg's board chair, an investor and key advisor. Rose said AI will help users and moderators without replacing human conversation.
"With Alexis on board, we bring a shared history, a deep respect for online communities, and a new perspective on what the internet needs today."
Ohanian said the goal of bringing Digg back is to build something different than existing social media platforms.
"Online communities thrive when there's a balance between technology and human judgment. We're bringing Digg back to ensure that balance exists," Ohanian said.
Ohanian said AI will "handle the grunt work" while humans focus on building real connections.
"No one dreams of spending their day hunting down spam or playing content police – they want to create, connect, and build thriving communities. I'm all in on this chapter."
Read Also: <a href="https://www.benzinga.com/news/22/12/29963917/reddit-co-founder-alexis-ohanian-prints-mean-tweets-and-screenshots-how-he-uses-them-as-motivation">Reddit Co-Founder Alexis Ohanian Prints Mean Tweets And Screenshots: How He Uses Them As Motivation</a>
Why It's Important: Digg launched in 2004 with a crowdsourced voting system that highlighted the top trending content. Once called the "homepage of the internet," Digg had 40 million monthly unique visitors at its peak.
Rose later sold Digg to Betaworks, with some of the company's assets, including patents, acquired by LinkedIn.
Digg is backed by True Ventures, where Rose is a partner and Seven Seven Six, founded by Ohanian.
Justin Mezzell, a longtime collaborator with Rose, will be Digg's new CEO. Mezzell previously worked at companies including Google, Facebook, Twitter and PayPal.
Digg's board of directors will include Mezzell, Rose, Ohanian, and Tony Conrad, a partner at True Ventures.
Once rivals due to the competition of Digg and Reddit, the storyline of Rose and Ohanian joining forces could make the reboot of Digg a top social media story to watch. The two entrepreneurs have been connected through several ventures in recent years with Ohanian investing in Moonbirds, an NFT project launched by Rose previously, before it was sold to Yuga Labs.
A successful reboot of Digg could be bad news for Reddit, as it would likely be the closest competitor based on the concept and with Ohanian on board could follow a similar structure.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/23/01/30471372/reddit-co-founder-alexis-ohanian-explains-investments-in-nfts-says-this-is-the-difference-">Reddit Co-Founder Alexis Ohanian Explains Investments In NFTs, Says This Is The Difference Web3 Provides</a></li>
</ul>
Image via Shutterstock

Social Media

RDDT

Social Media Founder Kevin Rose, Alexis Ohanian To Acquire & Reboot Digg: Old Rivals, New Vision

The White House has largely sidelined the issue of marijuana legalization, despite its widespread popularity. Amid a flurry of executive orders, foreign policy shifts and political spectacles, the Trump administration seems to have neglected what was once a clear trajectory toward reform.
"Unsurprisingly, much has been lost in the shuffle, including one salient, hugely popular issue: legal weed," <a href="https://newrepublic.com/article/192265/donald-trump-going-ruin-legal-marijuana">writes</a> Malcolm Ferguson in the New Republic.&nbsp;"This confusing, disorderly situation is being exacerbated by the fact that President Trump has never held a coherent position on marijuana."
Under <a href="https://www.benzinga.com/topic/president-joe-biden">President Biden</a>, federal marijuana policy saw notable progress. In October 2022, Biden acknowledged the government's approach to marijuana had been a failure and he moved to <a href="https://www.benzinga.com/markets/cannabis/24/05/38880719/biden-announces-monumental-marijuana-rescheduling-doj-to-take-next-steps">reclassify cannabis</a>. This led to a formal recommendation to reschedule marijuana from Schedule I to Schedule III, which the Drug Enforcement Agency <a href="https://www.benzinga.com/markets/cannabis/24/04/38531432/deas-move-to-reclassify-cannabis-seen-as-significant-but-fails-to-resolve-state-federal-conflict">approved in May</a>. However, little has been done since and the issue has disappeared from the national conversation since Trump took office in January.
Meanwhile, corporate cannabis firms continue expanding their dominance, complicating accessibility and consumer protection.
"The dissonance and inconsistency persist all while the drug soars in popularity and accessibility — and while large marijuana corporations rush to establish monopolies," noted Ferguson. 
During Trump's first campaign, he expressed tentative support for medical marijuana while opposing recreational use. Trump's 2024 <a href="https://www.benzinga.com/markets/cannabis/24/08/40666944/donald-trump-supports-cannabis-legalization-in-florida-game-changer-and-huge-blow-to-ron-desanti">endorsement of Florida's weed legalization</a> effort appeared more politically motivated than a reflection of a clear stance, noted Ferguson.
And now, with Trump's "right-wing, ‘law and order' Cabinet — it's not clear if he still supports reclassifying marijuana or if his administration even plans to do so." That said, the move toward legalization, Ferguson added, faces two likely paths, both of which could be detrimental to consumers.
One possibility is a corporate-driven legalization approach, heavily influenced by figures such as Elon Musk, who <a href="https://www.benzinga.com/markets/cannabis/23/02/30727642/elon-musk-tweets-a-simple-yet-powerful-pro-marijuana-message-reaches-millions-around-the-world">has voiced support</a> for cannabis. If Trump pursues this route, it could lead to industry consolidation by major multi-state operators (MSOs), prioritizing profit over consumer protection. 
&#8220;This would look like an even worse version of the current landscape,&#8221; warned Ferguson, with large companies squeezing out competition and focusing solely on maximizing potency and output.
Or, with Trump's socially conservative Cabinet which nearly across the board opposes legalization, the issue could remain on the back burner indefinitely.
Ultimately, Trump&#8217;s marijuana policy may hinge on which faction exerts the most influence — the Musk corporate interest group or the social conservatives. &#8220;Either way, both paths place politics, profit and production over people's health, safety and awareness,&#8221; Ferguson concludes.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/financing/25/03/44144069/big-tobaccos-latest-868m-cannabis-investment-signals-growing-industry-influence#google_vignette">Big Tobacco&#8217;s Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence</a></li>
</ul>
Photo: Shutterstock

Cannabis

Government

Legal

Trump May Lose Interest In Legal Marijuana During 'Disorderly Situation,' Conservative Cabinet, Says Analyst; Could Musk Come To The Rescue?

GFL Environment shares are trading higher after Scotiabank raised its price target on the stock from $50 to $52 and maintained a Sector Outperform rating.

Zscaler Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) will be reporting its second-quarter earnings on Wednesday. Wall Street expects 69 cents in EPS and $635.56 million in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=ZS" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is down 7.09% over the past year, up 5.54% year-to-date.
Let&#8217;s look at what the charts indicate for Zscaler stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/25/03/44141368/top-wall-street-forecasters-revamp-zscaler-price-expectations-ahead-of-q2-earnings">Top Wall Street Forecasters Revamp Zscaler Price Expectations Ahead Of Q2 Earnings</a>
<h2 class="wp-block-heading">Zscaler Stock Strongly Bearish Ahead Of Q2 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030525&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="627" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/05120635/Screenshot-2025-03-05-at-10.08.47-PM.png" alt="" class="wp-image-810636" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/05120635/Screenshot-2025-03-05-at-10.08.47-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/05120635/Screenshot-2025-03-05-at-10.08.47-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030525&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The company&#8217;s stock is currently in a strongly bearish trend, trading below its five-day, 20-day and 50-day exponential moving averages. The stock's price of $192.17 is below key simple moving averages, including the eight-day at $193.62, 20-day at $203.06 and 50-day at $195.44, all reinforcing the downward momentum.
Additionally, the Moving Average Convergence Divergence (MACD) indicator at a negative 2 suggests that bearish momentum remains intact.
However, there are signs of buying pressure, which could indicate a potential shift in sentiment. Zscaler's 200-day simple moving average at $188.51 is still below the current stock price, signaling longer-term support. Meanwhile, the Relative Strength Index (RSI) at 43.06 suggests that the stock is not yet oversold but could be approaching a level where buyers step in. 
Investors should monitor whether Zscaler stock can reclaim key moving averages, as a break above these resistance levels could confirm a bullish reversal.
<h2 class="wp-block-heading">Analysts See 16% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/ZS/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Zscaler stock stands at a Buy currently with a price target of $227.79. The latest analyst ratings from Rosenblatt, Barclays and Mizuho imply a 15.59% upside for Zscaler stock, with a $221.67 average price target.
Price Action: Zscaler stock was trading at $192 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44144570/3-cybersecurity-etfs-in-focus-amid-reports-of-us-cyber-operations-suspension">3 Cybersecurity ETFs in Focus Amid Reports of US Cyber Operations Suspension</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Tech

Trading Ideas

Zscaler Faces Bearish Pressure Before Q2: Can Earnings Spark A Reversal?

Financial giants have made a conspicuous bullish move on Intel. Our analysis of options history for Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) revealed 9 unusual trades.
Delving into the details, we found 55% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $646,371, and 4 were calls, valued at $336,899.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $18.0 to $60.0 for Intel during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intel's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intel's whale activity within a strike price range from $18.0 to $60.0 in the last 30 days. 
<h3>Intel Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741200382_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$13.7</td>
<td>$13.6</td>
<td>$13.65</td>
<td>$33.00</td>
<td>$294.8K</td>
<td>9.7K</td>
<td>216</td>
</tr>
<tr>
<td>INTC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.34</td>
<td>$2.19</td>
<td>$2.3</td>
<td>$18.00</td>
<td>$230.0K</td>
<td>53.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$2.18</td>
<td>$2.17</td>
<td>$2.18</td>
<td>$21.00</td>
<td>$156.5K</td>
<td>5.5K</td>
<td>1.6K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$2.32</td>
<td>$2.0</td>
<td>$2.0</td>
<td>$25.00</td>
<td>$76.4K</td>
<td>5.7K</td>
<td>0</td>
</tr>
<tr>
<td>INTC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.2</td>
<td>$1.12</td>
<td>$1.12</td>
<td>$21.00</td>
<td>$56.0K</td>
<td>24.6K</td>
<td>521</td>
</tr>
</tbody>
</table>

<h3>About Intel</h3>
Intel is a leading digital chipmaker, focused on the design and manufacturing of microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and was the prime proponent of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. Intel has also been expanding into new adjacencies, such as communications infrastructure, automotive, and the Internet of Things. Further, Intel expects to leverage its chip manufacturing capabilities into an outsourced foundry model where it constructs chips for others.
Following our analysis of the options activities associated with Intel, we pivot to a closer look at the company's own performance.
<h3>Intel's Current Market Status</h3>
<ul>
<li>Trading volume stands at 71,287,982, with INTC's price up by 0.14%, positioned at $21.36.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 50 days.</li>
</ul>
<h3>What The Experts Say On Intel</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $29.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Neutral rating on Intel, which currently sits at a price target of $29. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intel with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Comments

SPDR Gold MiniShares Trust

ニュース

最新ニュース SPDR Gold MiniShares Trust (ARCA:GLDM)

ニュース

パートナーシップ

ベンジンガ・グローバル